“drugs” Archives

in
Entry Author Date Location
East Coast Biotech Roundup: NY Disruptors, Commense, Regeneron, & More 04/01/16 Boston
What’s Ahead for Biotech in 2016: Q&A With BIO Chair Ron Cohen 03/31/16 New York
Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push 03/30/16 Texas
With New Data, Alder Keeps Pace in Migraine Drug Race 03/28/16 Seattle
West Coast Bio Roundup: Gilead, Affymetrix, Acutus, Frazier & More 03/25/16 San Diego
Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test 03/24/16 Boston
Big Data Meets Big Biology in San Diego, and Tickets Are Going Fast 03/22/16 San Diego
BioMarin Heads to FDA With Mixed Data For Rare Disease Drug 03/21/16 San Francisco
Tech Megatransfer: Merck Pays Harvard $20M For “Accelerated” Cancer Drugs 03/21/16 Boston
Bird Rock Bio Nears Pivotal Trial of New Biologic Drug for RA 03/16/16 San Diego
Celldex’s Brain Cancer Vaccine Fails Key Phase 3 Test, Shares Fall 03/07/16 Boston
HardTech Labs Names Veteran Biotech Scientist as Accelerator’s CTO 03/03/16 San Diego
JLabs @ TMC Opens Houston Campus, Home to 21 Biotech Startups 03/02/16 Texas
With Eye Drug Data, Aldeyra Takes a Small Step Forward in Inflammation 02/29/16 Boston
Soon-Shiong Makes Case for “Cancer MoonShot” at Biocom Conference 02/26/16 San Diego
Emphasizing Collaboration at a Pivotal Moment in Cancer Research 02/24/16 San Diego
How Aces in Big Data Play to San Diego’s Strong Suit in Big Biology 02/23/16 San Diego
Déjà Vu for PTC as FDA Declines to Consider Duchenne Drug App 02/23/16 New York
Roundup: Swift Biosciences, ONL, Application Deadlines, & More 02/19/16 Detroit Ann Arbor
West Coast Biotech Roundup: Grail, Juno, Amgen, Imprimis & More 02/12/16 San Diego
TRImaran Licenses WSU Compounds to Develop Neuro Drugs 02/11/16 Detroit Ann Arbor
12 San Diego Life Sciences Startups to Watch in 2016 02/09/16 San Diego
ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics 02/04/16 San Diego
West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More 01/29/16 San Diego
Safety Issues Spur Foundation-Backed Akashi to Suspend Duchenne Trial 01/26/16 Boston
OncoMed Shares Fall After Discouraging News on Pancreatic Cancer Drug 01/25/16 San Francisco
East Coast Biotech Roundup: Alkermes, Zafgen, Snowmaggedon & More 01/22/16 Boston
Depression Trials Fail, Alkermes Sees Silver Lining. Investors Don’t. 01/21/16 Boston
Some Good News, Finally, for Zafgen’s Obesity Drug 01/20/16 Boston
With Second Eye Drug Flop, Eleven Heads Back to Drawing Board 01/19/16 Boston
Page 4 of 90 « previous page · next page »